financetom
Business
financetom
/
Business
/
What's Going On With Rivian (RIVN) Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Rivian (RIVN) Stock?
May 26, 2025 8:59 AM

Rivian Automotive Inc ( RIVN ) shares are trading higher and trending Thursday. Here's what investors are watching with Rivian this week.

What To Know: The electric vehicle maker posted better-than-expected first-quarter results on May 6, reporting revenue of $1.24 billion (up 3% year-over-year) and a narrower-than-expected loss of 48 cents per share. Gross profit came in at $206 million—its second consecutive positive quarter—driven by improved cost efficiency and operational progress.

CEO RJ Scaringe emphasized Rivian’s ongoing development of the R2 platform, with validation builds underway and its Illinois facility expansion on track. The R2, expected to launch in the first half of 2026, will enter the market at a starting price of $45,000, a level Rivian is maintaining despite rising tariffs. The company estimates per-unit tariff costs of around $2,000 in 2025.

Read Also: Plug Power Stock Hits A New 52-Week Low: What’s Going On?

Rivian also highlighted new milestones: a record 36,000 demo drives in the first-quarter, a fleet deal with HelloFresh and a $1 billion investment from Volkswagen set to close mid-2025. However, the company revised its 2025 delivery guidance downward to 40,000–46,000 vehicles, citing macroeconomic and trade uncertainties.

Adding some potential pressure this week, a new GOP-led House bill aims to eliminate EV tax credits and rescind billions in clean vehicle loan funding—including $6.57 billion allocated to Rivian.

Read Also: NIO Stock Is Sliding Thursday: What’s Going On?

Price Action: Shares of Rivian have climbed 10% over the past week, trading at $15.22 Thursday afternoon.

How To Buy RIVN Stock

By now you're likely curious about how to participate in the market for Rivian Automotive ( RIVN ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, RIVN has a 52-week high of $18.86 and a 52-week low of $9.50.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vizsla Silver Down 2.1% in US Premarket as Agrees to Buy Claims Near Panuco Project in Mexico
Vizsla Silver Down 2.1% in US Premarket as Agrees to Buy Claims Near Panuco Project in Mexico
Apr 16, 2024
08:23 AM EDT, 04/16/2024 (MT Newswires) -- Vizsla Silver ( VZLA ) was at last look down 2.1% in US premarket on Tuesday after agreeing to acquire two large claims located south and partially adjacent to the company's Panuco project in Mexico. The just-acquired San Enrique prospect, which is almost 50% larger than Panuco, is located along the highly prospective...
Foghorn Therapeutics Names Kristian Humer CFO
Foghorn Therapeutics Names Kristian Humer CFO
Apr 16, 2024
08:16 AM EDT, 04/16/2024 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) said Tuesday that Kristian Humer has been named chief financial officer, effective immediately. Humer most recently served as CFO and chief business officer at Viridian Therapeutics ( VRDN ) , the company said. ...
GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review
GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review
Apr 16, 2024
08:14 AM EDT, 04/16/2024 (MT Newswires) -- GSK (GSK) said in a regulatory filing Tuesday that the US Food and Drug Administration has accepted for review the company's biologics license application for its meningococcal ABCWY vaccine candidate. The pharmaceutical giant said the vaccine candidate provides broad coverage against the five most common groups of bacteria causing invasive meningococcal disease, and...
TELUS International Up 1% In US Premarket As It Expands Partnership With Nasdaq-listed Appian
TELUS International Up 1% In US Premarket As It Expands Partnership With Nasdaq-listed Appian
Apr 16, 2024
08:18 AM EDT, 04/16/2024 (MT Newswires) -- TELUS International , a digital customer experience (CX) innovator, was at last look up 1% in US premarket after saying Tuesday that it has expanded its partnership with Appian to help clients accelerate business processes and application development via intelligent automation as a service (AaaS) platform that incorporates Appian's low-code application development capabilities....
Copyright 2023-2026 - www.financetom.com All Rights Reserved